Abstract:Purpose High‐quality CBCT and AI‐enhanced adaptive planning techniques allow CBCT‐guided stereotactic adaptive radiotherapy (CT‐STAR) to account for inter‐fractional anatomic changes. Studies of intra‐fractional respiratory motion management with a surface imaging solution for CT‐STAR have not been fully conducted. We investigated intra‐fractional motion management in breath‐hold Ethos‐based CT‐STAR and CT‐SBRT (stereotactic body non‐adaptive radiotherapy) using optical surface imaging combined with onboard CBCTs. Methods Ten cancer patients with mobile lower lung or upper abdominal malignancies participated in an IRB‐approved clinical trial (Phase I) of optical surface image‐guided Ethos CT‐STAR/SBRT. In the clinical trial, a pre‐configured gating window (± 2 mm in AP direction) on optical surface imaging was used for manually triggering intra‐fractional CBCT acquisition and treatment beam irradiation during breath‐hold (seven patients for the end of exhalation and three patients for the end of inhalation). Two inter‐fractional CBCTs at the ends of exhalation and inhalation in each fraction were acquired to verify the primary direction and range of the tumor/imaging‐surrogate (donut‐shaped fiducial) motion. Intra‐fractional CBCTs were used to quantify the residual motion of the tumor/imaging‐surrogate within the pre‐configured breath‐hold window in the AP direction. Fifty fractions of Ethos RT were delivered under surface image‐guidance: Thirty‐two fractions with CT‐STAR (adaptive RT) and 18 fractions with CT‐SBRT (non‐adaptive RT). The residual motion of the tumor was quantified by determining variations in the tumor centroid position. The dosimetric impact on target coverage was calculated based on the residual motion. Results We used 46 fractions for the analysis of intra‐fractional residual motion and 43 fractions for the inter‐fractional motion analysis due to study constraints. Using the image registration method, 43 pairs of inter‐fractional CBCTs and 100 intra‐fractional CBCTs attached to dose maps were analyzed. In the motion range study (image registration) from the inter‐fractional CBCTs, the primary motion (mean ± std) was 16.6 ± 9.2 mm in the SI direction (magnitude: 26.4 ± 11.3 mm) for the tumors and 15.5 ± 7.3 mm in the AP direction (magnitude: 20.4 ± 7.0 mm) for the imaging‐surrogate, respectively. The residual motion of the tumor (image registration) from intra‐fractional breath‐hold CBCTs was 2.2 ± 2.0 mm for SI, 1.4 ± 1.4 mm for RL, and 1.3 ± 1.3 mm for AP directions (magnitude: 3.5 ± 2.1 mm). The ratio of the actual dose coverage to 99%, 90%, and 50% of the target volume decreased by 0.95 ± 0.11, 0.96 ± 0.10, 0.99 ± 0.05, respectively. The mean percentage of the target volume covered by the prescribed dose decreased by 2.8 ± 4.4%. Conclusion We demonstrated the intra‐fractional motion‐managed treatment strategy in breath‐hold Ethos CT‐STAR/SBRT using optical surface imaging and CBCT. While the controlled residual tumor motion measured at 3.5 mm exceeded the predetermined setup value of 2 mm, it is important to note that this motion still fell within the clinically acceptable range defined by the PTV margin of 5 mm. Nonetheless, additional caution is needed with intra‐fractional motion management in breath‐hold Ethos CT‐STAR/SBRT using optical surface imaging and CBCT.

Evaluation of setup and intrafraction motion for surface guided whole‐breast cancer radiotherapy

New findings on clinical experience on surface-guided radiotherapy for frameless non-coplanar stereotactic radiosurgery treatments

Accuracy and potential improvements of surface-guided breast cancer radiotherapy in deep inspiration breath-hold with daily image-guidance

Real-time intra-fraction motion management in breast cancer radiotherapy: analysis of 2028 treatment sessions

Verification of surface‐guided radiation therapy (SGRT) alignment for proton breast and chest wall patients by comparison to CT‐on‐rails and kV‐2D alignment

Setup margins based on the inter‐ and intrafractional setup error of left‐sided breast cancer radiotherapy using deep inspiration breath‐hold technique (DIBH) and surface guided radiotherapy (SGRT)

Feasibility of Optical Surface-Guidance for Position Verification and Monitoring of Stereotactic Body Radiotherapy in Deep-Inspiration Breath-Hold

Clinical Validation of two Surface Imaging Systems for Patient Positioning in Percutaneous Radiotherapy

Use of surface tracking recordings to identify pitfalls during surface-guided radiotherapy

Detection of Setup Errors with Body Surface Laser Scanning for Whole Breast Irradiation after Conservative Surgery

Characterization of the IDENTIFYTM surface scanning system for radiation therapy setup on a closed‐bore linac

Feasibility of surface‐guidance combined with CBCT for intra‐fractional breath‐hold motion management during Ethos RT

Skin marker combined with surface‐guided auto‐positioning for breast DIBH radiotherapy daily initial patient setup: An optimal schedule for both accuracy and efficiency

Innovative integration of augmented reality and optical surface imaging: A coarse‐to‐precise system for radiotherapy positioning

Application of optical surface monitoring system(OSMS) during postoperative radiotherapy for breast cancer patients immobilized with neck and thorax thermoplastic mask

An Evaluation of Intrafraction Motion

Performance assessment of the surface-guided radiation therapy system: Varian Identify

Initial clinical experience of surface guided stereotactic radiation therapy with open-face mask immobilization for improving setup accuracy: a retrospective study

Optical Surface Management System and BladderScan for Patient Setup During Radiotherapy of Postoperative Prostate Cancer

Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy

Assessment of Setup Accuracy Using Anatomical Landmarks for Breast and Chest Wall Irradiation With Surface Guided Radiation Therapy